Greenyn Biotechnology (6846.TWO) Earnings Analysis

Greenyn Biotechnology (6846.TWO) next reports earnings on 2026-08-19. Last quarter (2026-03-10) it missed with EPS 1.89 TWD vs 2.51 TWD est (-24.7%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E 12.99.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6846.TWO next report earnings?

Next earnings date2026-08-19
Consensus EPS estimaten/a
Revenue estimaten/a

6846.TWO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-101.89 TWD2.51 TWD-24.7%Miss
2025-11-070.91 TWD1.5 TWD-39.3%Miss
2025-05-081.62 TWD1.47 TWD+10.2%Beat
2025-03-101.84 TWD1.5 TWD+22.7%Beat
2024-11-081.08 TWD1.06 TWD+1.9%Beat

Beat rate: 3/5 (60%) over reported quarters with consensus data.

6846.TWO valuation and analyst view

Trailing P/E12.99
Trailing EPS4.885 TWD
Price / book1.90
Dividend yield6.21%
Market cap1.73B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Greenyn Biotechnology (6846.TWO)'s next earnings date?

Greenyn Biotechnology is next scheduled to report on 2026-08-19.

Did 6846.TWO beat earnings last quarter?

In its 2026-03-10 report, 6846.TWO posted EPS of 1.89 TWD versus a 2.51 TWD estimate — a miss of 24.7%.

What is 6846.TWO's earnings track record?

Over the last 5 reported quarters with consensus data, 6846.TWO beat estimates 3 times (60%).

What is 6846.TWO's current P/E ratio and EPS?

6846.TWO trades at a trailing P/E of 12.99 on trailing EPS of 4.8846082813134855 TWD.

What do analysts rate 6846.TWO?

6846.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.